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Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala.

Heroin administration alters the induction of nitric oxide, a molecule known to play a critical role
in immune function. Previous research has shown that these alterations can be conditioned to
environmental stimuli that have been associated with drug administration. Little is known about
the brain areas that mediate these effects; however, the basolateral amygdala (BLA) has been
implicated in the formation of stimulus–reward associations within models of drug abuse. The
present study sought to determine whether inactivation of the BLA would alter heroin's
conditioned effects on the expression of inducible nitric oxide synthase (iNOS) and the
proinflammatory cytokines TNF‐α and IL‐1β in the rat. The conditioning procedure involved
repeated pairing of heroin with placement into a standard conditioning chamber. To test the
conditioned response, animals were returned to the previously drug‐paired environment 6

days

after the final conditioning session. Prior to testing, animals received intra‐BLA microinfusions of
a mixture of the GABA agonists muscimol and baclofen. Following removal from the chambers
on test day, all animals received subcutaneous lipopolysaccharide to induce systemic expression
of iNOS, TNF‐α and IL‐1β. Analyses using real‐time RT‐PCR indicated that inactivation of the
BLA blocked the suppressive effect of heroin‐associated environmental stimuli on iNOS induction
and on the expression of the proinflammatory cytokines TNF‐α and IL‐1β in spleen and liver
tissue. This study is important because it is the first to demonstrate that heroin's conditioned effects

on proinflammatory mediators require the BLA. These findings may have significant implications
for the treatment of heroin users.
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Exposure to drug cues is one of the key contributing factors to relapse, mainly because these cues
induce a wide variety of complex, classically conditioned physical and behavioral responses ([39];
[ 7]). There has been increasing evidence from studies conducted on human subjects showing that
drug‐paired stimuli can cause intense craving, feelings of being 'high' and altered neural activity
in drug users ([36]; [ 9]). Current research in the area of drug addiction has focused on the critical
task of reducing relapse by attempting to curb cue‐induced drug seeking behavior; however, it is
also imperative to take into account the widespread effects these cues may have on immune
functioning and the ability of previous drug users to combat infectious disease while in recovery.

Research in our laboratory and others has shown that not only will administration of heroin
suppress a number of basic immune parameters but many of these suppressive effects on the
immune system may also be conditioned to environmental cues that predict drug availability. For
instance, rats re‐exposed to a previously morphine‐paired environment display alterations in basic
immune parameters similar to those seen upon actual morphine administration including decreased
mitogen responsiveness of lymphocytes, decreased natural killer cell activity and suppressed IL‐2
production ([ 6]; [32]. In line with these studies, it has been shown that heroin administration
results in a profound reduction in lipopolysaccharide (LPS)‐induced nitric oxide expression ([19])
and this effect on nitric oxide may be conditioned to environmental stimuli that predict drug

availability ([20]). In addition to effects on nitric oxide, there is evidence that opiate administration
may also alter the production of the proinflammatory cytokines tumor necrosis factor‐alpha (TNF‐
α) and interleukin‐1 beta (IL‐1β) ([ 4]; [24]). Given the critical nature of these proinflammatory
mediators in the initial response to infection it is imperative that we understand how heroin and
heroin‐related cues may alter their effectiveness.

Little is known about the brain areas involved in these conditioned effects; however, the basolateral
amygdala (BLA) has been implicated in the formation of stimulus–reward associations within
models of drug abuse. For example, inactivation of the BLA blocks the ability of drug cues to
reinstate drug seeking in rats that had been previously taught to self‐administer cocaine ([21];
[11]). In a similar study, inactivation of the BLA was shown to abolish cue‐induced reinstatement
of drug seeking in rats taught to administer heroin ([10]). The current experiment sought to
establish the role of the BLA in the conditioned effects of heroin on nitric oxide by quantifying
inducible nitric oxide synthase (iNOS) expression in spleen and liver tissue following inactivation
of the BLA. In addition, IL‐1β and TNF‐α were measured in these same tissues to determine
whether exposure to stimuli previously paired with heroin would alter the expression of these
cytokines and whether inactivation of the BLA would have an effect on these conditioned
alterations.
Materials and methods

Animals

Male Lewis rats, weighing 225–250

g, were purchased from Charles River Laboratories

(Raleigh, NC, USA). Upon arrival, animals were housed individually in plastic cages in a colony
room with a reversed light‐dark (12‐h) cycle maintained through artificial illumination. Animals
were allowed access to food and water ad libitum throughout the experiment except for the time
spent in the conditioning chambers when food and water were not available. All animals were
given a 2‐week habituation period before the start of experimental manipulations and were handled
regularly during this time. All procedures described were approved by the IACUC of the
University of North Carolina at Chapel Hill and conformed to National Institutes of Health (NIH)
Guidelines on the Care and Use of Laboratory Animals.
Drug administration

Heroin (diacetylmorphine) was obtained from NIDA (Bethesda, MD, USA) and dissolved in 0.9%
sterile saline. For all experiments, animals received a subcutaneous injection of heroin at a dose 1
mg/kg immediately prior to placement in the conditioning chamber on each of the five
conditioning trial days. This dose was selected based on prior experiments in our laboratory
showing that a 1

mg/kg dose of heroin alters LPS‐induced iNOS mRNA expression in spleen

and liver tissue and induces conditioning ([19]; [20]; [37]).
Surgeries and microinjections

Animals were anesthetized with 0.35
ketamine hydrochloride (100

mL intramuscular injections of 1

mg/mL) mixed with xylazine (20

:

1 (vol :

vol)

mg/mL) and placed into the

stereotaxic apparatus. Animals were implanted with 26‐gauge bilateral guide cannulae (Plastics
One, Roanoke, VA, USA) directed towards the BLA (AP −2.5, ML

±

5.0, DV −6.6

mm) or

caudate control region (AP −2.4, ML

±

4.5, DV −4.0

mm). Coordinates are expressed

relative to bregma ([26]).

Animals were given a 2‐week recovery period before the start of conditioning trials. On test day,
animals received bilateral intracranial injections (0.3

μL per side infused over 1

vehicle or a combination of GABA agonists, muscimol (0.03
30

min) of saline

nmol) and baclofen (0.3

nmol),

min prior to re‐exposure to the conditioning chambers to determine whether the brain areas

inactivated are necessary for the conditioned alterations in proinflammatory mediators. Injectors
extended 2 mm beyond the tip of the cannula and were left in place for 1

min after the injection

to allow for proper infusion.
Procedures

Acquisition of conditioned response

All animals received five 60‐min training sessions in which they were administered a subcutaneous
injection of heroin (1 mg/kg) upon placement into a standard conditioning chamber which served
as the conditioned stimulus. Training sessions were separated by 48

h. The conditioning

chambers (BRS/LVE, Laurel, MD, USA) were contained in a room separate from the animal
colony. Chambers were fitted with a metal grid floor design and cedar bedding to create an
environment distinct from that of the home cage and to provide both olfactory and tactile cues for
conditioning. All conditioning took place during the dark phase of the light cycle and the
conditioning chambers were kept dark to minimize effects on circadian rhythms.
Testing of expression of conditioned response

The test day took place 6

days following the final conditioning session. Thirty minutes prior to

testing, two groups of animals, Mus/Bac–BLA and Mus/Bac–caudate (Caud) received,
respectively, intra‐BLA and intracaudate microinfusions of the combination of GABA agonists
muscimol and baclofen to temporarily inactivate the BLA or caudate. Control animals received
intra‐BLA or intracaudate microinfusions of saline vehicle (groups Saline–BLA and Saline–
Caud). To test the expression of the conditioned response, two groups of animals were re‐exposed
to the conditioned stimulus (i.e.; the conditioning chambers) without drug to determine whether
the conditioned stimulus alone would induce alterations in proinflammatory mediators. Animals
re‐exposed to the conditioning chambers on test day are indicated in the figures as CS. The
remaining animals (HC) were returned to the home cage following microinfusions and served as
controls. Experimental treatment of each group is outlined in Table 1. After the 60‐min re‐
exposure, the animals were removed from the chambers and given a subcutaneous injection of LPS
(1000 μg/kg) to induce iNOS production in spleen and liver tissue. HC animals also received
LPS at this time. Six hours after LPS administration all animals were killed by cervical dislocation
and samples of spleen, liver and blood were collected for analysis. The 6‐h timepoint was selected
based on previous research in our laboratory showing maximal iNOS induction at 6

h following

LPS administration ([19]).

1 Schematic representation of the behavioral and pharmacological manipulations employed for
each treatment group
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Real‐time RT‐PCR

To determine iNOS expression, real time RT‐PCR was performed on tissue samples from the
spleen and liver. Total RNA was extracted from a section of each of the tissues using TRI‐Reagent

(Molecular Research Center, Cincinnati, OH, USA), a modification of the original method
described by [ 5]. RNA was quantified spectrophotometrically (GeneQuant

II; Pharmacia‐

Biotech, Piscataway, NJ, USA). For the RT‐PCR, reverse transcription is performed using
Oligo(dT)18 primer and Moloney Murine Leukemia Virus‐Reverse transcriptase following the
protocol of the Advantage RT‐for‐PCR Kit from Clontech (Palo Alto, CA, USA).

PCR amplifications were performed using the Fast Start™ DNA Master SYBR Green

I Real‐

Time PCR Kit (Roche) and the LightCycler instrument (Roche). A master mix containing all
reaction components was prepared for all reactions, with each reaction using a 20‐mL mix placed
in glass capillary tubes specifically designed for use in the LightCycler system. The PCR primer
set

for

iNOS,

5′‐CCCTTCCGAAGTTTCTGGCAGCAGC‐3′

and

5′‐GGGTGTCAGA‐

GTCTTGTGCCTTTGG‐3′ was synthesized by the Nucleic Acids Core Facility (Lineberger
Cancer Center, UNC‐Chapel Hill, NC, USA). Copy numbers were generated from an external
standard curve. Amplifications were carried out for 40 cycles and curves showing fluorescence at
each cycle were determined by the computer software (Roche). Samples were preincubated for 10
min at 95°C to activate the Fast‐Start Taq DNA polymerase. The cycle temperatures were 95, 60,
and 72°C for the denaturing, annealing and extending, respectively. The cycle times were 15, 5
and 25

s for the denaturing, annealing and extending, respectively. Fluorescence level was

determined at the end of the extending phase for each cycle of PCR. The analysis of the
fluorescence level in standards and samples over the course of 40 cycles was used to derive the
number of copies of the target molecule in each sample. Additionally, assessments of
housekeeping gene, cyclophilin, expression were made to assure comparable quality of RNA
among samples. The sequence of the cyclophilin primers was 5′‐CCAAGACTGAGTGGCT‐3′

and 5′‐AGATTACAGGGTATTGCG‐3′. The data are expressed as a copy number of iNOS (per
10

ng cDNA) based on the standard curve using the LightCycler software (Roche). Furthermore,

to confirm the nature of the amplification product, a melt curve analysis was conducted after the
final PCR cycle. This analysis involved denaturing the products by slowly heating them to 95°C,
during which fluorescence was continuously measured.
ELISA

For IL‐1β and TNF‐α protein determinations, protein was extracted from a section of each tissue
using freeze–thaw lysis in Tris buffer containing antiproteinases. Protein was quantified
spectrophotometrically (Model EL312 kinetic reader; Bio‐Tek, Winooski, VT, USA) using Bio‐
Rad protein dye. The BioSource International, Inc. (Carlsbad, CA, USA) rat IL‐1β and TNF‐α
ELISA test kits were used to determine the levels of IL‐1β or TNF‐α protein in each tissue sample.
Briefly, samples and standards were added to microtiter wells coated with antibody that recognizes
IL‐1β or TNF‐α and incubated at room temperature. Wells were washed extensively and then
incubated with biotinylated antibody, followed by a second wash and then incubation with
streptavidin–HRP. After the final washing, a chromagen substrate solution was added which
reacted with the bound enzyme to produce color. The color intensity developed proportionally to
the amount of IL‐1β or TNF‐α present in each sample. The enzyme reaction was stopped after 30
min, and the absorbance at 450

nm was measured with a Bio‐Tek Model EL312 kinetic reader.

A standard curve was obtained by plotting the absorbance versus the corresponding concentrations
of the supplied standards.
Nitrite/nitrate assay

The ratio of nitrite to nitrate in plasma samples was assessed using the Greiss reagent assay. Nitrate
and nitrite are formed nonenzymatically when nitric oxide is exposed to oxygen; plasma levels of
these products thus indicate the level of nitric oxide production. Total nitrite/nitrate was
determined by the conversion of nitrate to nitrite utilizing nitrate reductase in the presence of
NADPH and flavin adenine dinucleotide, and then an assessment using Greiss reagent. Briefly, 6
μL of plasma diluted in 44
nitrate reductase (1.0

μL of dH2O was incubated in the dark for 90

U/mL), 20

min with 10

μL of a 0.31‐m phosphate buffer (pH 7.5), 10

μL of

μL of 0.86

mm NADPH (Sigma) and 10

μL of a 0.11‐mm flavin adenine dinucleotide in individual wells

of a 96‐well plate. Then, 200

mL of Greiss reagent consisting of a 1

:

1 (v

:

v) solution

of 1% sulfanilamide in 5.0% phosphoric acid and 0.1%N‐(1‐napthyl) ethyl‐enedamine
dihydrochloride in distilled water was added to the samples. The color developed for 10

min at

room temperature after which the absorbance was determined using a spectrophotometer set at 550
nm. All reactions were carried out in triplicate. The total micromolar concentration of nitrite was
determined for each sample based on a standard curve. Recovery of nitrate was >

95% using this

assay.
Statistical analysis

anova was performed on all data sets. When the overall anova showed significant effects, post hoc
comparisons were made using Tukey's test to compare individual treatment groups. All analyses
were conducted with the level of significance set at P
Histology

< 0.05.

To confirm proper cannula placement Alcian blue dye was infused via the cannula following
killing. Brains were then extracted and post‐fixed in a 4% paraformaldehyde solution. Following
fixation the brains were transferred to a 30% sucrose solution for cryoprotection and then frozen
at −80°C until further analysis. Coronal sections (50

μm) were taken and stained with Cresyl

violet for verification of cannula placement. Animals with cannula placement outside of the
targeted region were removed from the analyses. Figure 1 shows a schematic diagram illustrating
the most ventral point of the injection cannula for each animal in the study. Figure 2 is a
representative photomicrograph showing the injection cannula tract to the BLA.

Graph: 1 BLA injection cannula placement was verified by Cresyl violet‐stained coronal sections.
Symbols in the diagram represent the most ventral point of the injection cannula for each animal
in the study, based on the atlas of [26]. AP coordinates indicate the distance from bregma in mm.
(CS

saline: black circles; CS

Mus/Bac: gray squares; n

Mus/Bac: gray circles; HC

saline: black squares; HC

= 4 per group)

Graph: 2 Representative photomicrograph showing the cannula tract and site of injection within
the BLA on a Cresyl violet‐stained coronal section. The arrow indicates the most ventral point of
the injector cannula tract.
Results

Effects of BLA inactivation on conditioned heroin‐induced suppression of nitric oxide express...

The first study investigated whether inactivation of the BLA or caudate control region immediately
before testing (exposure to the previously drug‐paired environment) would alter the conditioned
effects of heroin on nitric oxide production. Six days following the final conditioning session, half
of the animals (CS) were re‐exposed to the previously heroin‐paired environment for 60

min

while the other half (HC) remained in the home cage and served as control groups. In order to
temporarily inactivate the brain regions under investigation, animals in the Mus/Bac‐BLA and
Mus/Bac‐Caud groups received microinfusions of the muscimol–baclofen combination directly
into the BLA or caudate, respectively, 30

min prior to testing. The animals in the Saline‐BLA

and Saline‐Caud groups received microinfusions of saline into these same areas.

Figure 3A shows the results of each treatment on LPS‐induced expression of iNOS mRNA in the
spleen and liver following inactivation of the BLA. Analysis of iNOS copy number in spleen and
liver revealed a significant main effect of treatment [F( 4,15)
= 9.432, P

= 10.711, P

< 0.01; F( 4,15)

< 0.01]. Moreover, there was a significant difference in iNOS mRNA copy

number between the animals exposed to the conditioned stimulus on test day who had received
intra‐BLA saline (CS

Saline‐BLA) and the animals who remained in the home cage on test day

and received intra‐BLA saline (HC
(P

Saline‐BLA). These differences were evident in both tissues

< 0.05), which supports our earlier findings indicating that exposure to a previously heroin‐

paired environment alters the expression of iNOS mRNA. Most importantly, there were no
significant differences between the HC

Saline‐BLA group and the experimental group that

received intra‐BLA microinjections of muscimol–baclofen before exposure to the conditioned
stimulus on test day (CS

Mus/Bac‐BLA), demonstrating the ability of BLA inactivation to

reduce the conditioned response. Furthermore, there were no significant differences between the

HC

Saline‐BLA group and the group that received intra‐BLA muscimol and baclofen but

remained in the home cage on test day (HC

Mus/Bac‐BLA), indicating that these results are

specific to administration of drug and not due to ancillary effects of the microinjections. There
were also no differences found in expression of the housekeeping gene, cyclophilin, between any
of the groups, indicating that the alterations in mRNA were specific to iNOS and not the result of
an overall reduction in RNA expression or production (data not shown).

Graph: 3 Effect of treatments on LPS‐induced expression of iNOS mRNA in the spleen (A and B)
and liver (C and D) as determined by real‐time RT‐PCR. Re‐exposure to the previously heroin‐
paired environment (CS, conditioned stimulus) reduced iNOS mRNA in both spleen and liver
tissue and this reduction was attenuated by inactivation of the BLA (A and C) but not affected by
inactivation of the caudate control region (B and D). Data are expressed as iNOS copy number per
10

ng cDNA based on a standard curve using Roche LightCycler software. *P

< 0.05 vs. the

HC (home cage) Saline‐BLA/Caud group.

Figure 3B also shows the effects of each treatment on LPS‐induced expression of iNOS mRNA in
the spleen and liver following inactivation of the caudate control region. Analysis of iNOS copy
number in spleen and liver revealed a significant main effect of treatment [F( 4,15) = 6.458, P
< 0.05; F( 4,15) =

6.868, P

Saline‐Caud group and the HC

< 0.01]. There was a significant difference between the CS
Saline‐Caud group in both tissues (P

< 0.05), which is in

agreement with the data from our previous research. Most importantly, there was also found to be
a significant difference between the HC

Saline‐Caud group and the experimental group that

received intracaudate microinjections of muscimol–baclofen that was re‐exposed to the

conditioned stimulus on test day (CS

Mus/Bac‐Caud), indicating that this region is not involved

in the conditioned effects of heroin on iNOS mRNA expression (P
were no significant differences between the HC

< 0.05). Furthermore, there

Saline‐Caud group and the HC

Mus/Bac‐Caud

group, indicating that these results are specific to administration of drug and not due to ancillary
effects of the microinjections.

The data in Fig. 4 show the effects of (A) BLA and (B) caudate control region inactivation on
serum nitrite/nitrate levels. Nitrite and nitrate are byproducts of nitric oxide production and levels
of these markers serve as an indirect analysis of nitric oxide levels in the blood. For the BLA
inactivation experiment, examination of nitrite/nitrate levels in the serum revealed a significant
main effect of treatment [F( 4,15)
the CS

= 13.939, P

Saline‐BLA group and the HC

< 0.01] and a significant difference between

Saline‐BLA group (P

<

0.05), indicating that

exposure to a previously heroin‐paired environment reduces the production of nitric oxide. There
were no significant differences between the HC

Saline‐BLA group and the CS

Mus/Bac‐BLA

group, demonstrating that inactivation of the BLA reduces the conditioned effects of heroin on
nitric oxide. Taken together, these findings show that inactivation of the BLA will reduce the
conditioned effects of heroin on nitric oxide production.

Graph: 4 Effect of treatments on serum nitrite/nitrate levels as determined by the Greiss reagent
assay. Re‐exposure to the previously heroin‐paired environment (CS) reduced serum levels of
nitrite/nitrate and this reduction was (A) attenuated by inactivation of the BLA but (B) not affected
by inactivation of the caudate control region. The data are expressed as the micromolar
concentration of nitrite/nitrate. *P

< 0.05 vs. the HC

Saline‐BLA or ‐Caud group.

For the caudate control region experiment, anova revealed a significant main effect of treatment
[F( 4,15)

= 16.767, P

Caud group and the HC
group and the HC

< 0.01] and a significant difference both between the CS
Saline‐Caud group (P

Saline‐Caud group (P

<

< 0.01) and between the CS

Saline‐

Mus/Bac‐Caud

0.01). These results indicate that exposure to a

previously heroin‐paired environment reduces the production of nitric oxide and this effect is not
attenuated by inactivation of this region of the caudate.
Effects of BLA inactivation on conditioned heroin‐induced suppression of proinflammatory cyto...

Figure 5 shows that the suppressive effect of heroin on the proinflammatory cytokine IL‐1β can
be conditioned to environmental stimuli and this conditioned effect is reduced by inactivation of
the BLA. This effect was evident at both the protein and mRNA levels and in both spleen and liver
tissue. Analysis revealed a main effect of treatment on both mRNA and protein levels in the spleen
[F( 4,15) = 6.546, P
7.993, P
the CS

< 0.01; F( 4,15)

< 0.01; F( 4,15)

= 21.964, P

=

38.871, P

< 0.01] and liver [F( 4,15)

=

<

0.01]. In line with our previous experiments,

Saline‐BLA group exhibited significantly lower levels of IL‐1β mRNA and protein in

both the spleen and liver (P

< 0.05) as compared to the HC

Mus/Bac‐BLA group was not significantly different from the HC

Saline‐BLA group. The CS
Saline‐BLA group, indicating

that inactivation of the BLA was able to reverse the conditioned effects of heroin on IL‐1β mRNA
and protein expression.

Graph: 5 Effect of treatments on LPS‐induced expression of IL‐1β mRNA and protein in (A and
C) the spleen and (B and D) liver as determined by real‐time RT‐PCR. Re‐exposure to the

previously heroin‐paired environment (CS) reduced IL‐1β mRNA and protein in both spleen and
liver tissue and this reduction was attenuated by inactivation of the BLA. The RT‐PCR data (A
and B) are expressed as IL‐1β copy number per 10

ng cDNA based on a standard curve using

Roche LightCycler software. (C and D) The ELISA data are expressed as pg of protein per ml. *P
< 0.05 vs. the HC

Saline‐BLA group.

Figure 6 shows that the suppressive effect of heroin on the proinflammatory cytokine IL‐1β can
be conditioned to environmental stimuli and this conditioned effect is not altered by inactivation
of the caudate control region. This effect was evident at both the protein and mRNA levels in the
spleen and at the protein level in liver tissue. As the time of tissue collection was optimized for
iNOS analysis it is not surprising that there was no significant effect at this timepoint in liver IL‐
1β mRNA levels. As the effect is evident at the protein level this suggests that it might also have
been present at the mRNA level at an earlier timepoint. Analysis revealed a main effect of
treatment on both mRNA and protein levels in the spleen [F( 4,15)
4,15) = 21.585, P

<

0.01] and on protein in the liver [F( 4,15)

line with our previous experiments, the CS

= 20.141, P

< 0.01; F(

= 7.993, P

< 0.01]. In

Saline‐Caud group exhibited significantly lower

levels of IL‐1β mRNA and protein in the spleen and in protein in the liver (P
compared to the HC

Saline‐Caud group. The CS

< 0.05) as

Mus/Bac‐BLA group also exhibited

significantly lower IL‐1β protein and mRNA (except for liver mRNA which showed the same
trend but was not significant) compared with the HC

Saline‐Caud group, indicating that

inactivation of the caudate control region was not able to reverse the conditioned effects of heroin
on IL‐1β mRNA and protein expression.

Graph: 6 Effect of treatments on LPS‐induced expression of IL‐1β mRNA and protein in (A and
C) the spleen and (B and D) liver as determined by real‐time RT‐PCR. Re‐exposure to the
previously heroin‐paired environment (CS) reduced IL‐1β mRNA and protein in the spleen and
IL‐1β protein in liver tissue, and this reduction was not altered by inactivation of the caudate
control region. (A and B) The RT‐PCR data are expressed as IL‐1β copy number per 10

ng

cDNA based on a standard curve using Roche LightCycler software. (C and D) The ELISA data
are expressed as pg of protein per ml. *P

< 0.05 vs. the HC

Saline‐Caud group.

Figure 7 shows that the suppressive effect of heroin on the proinflammatory cytokine TNF‐α can
also be conditioned to environmental stimuli and, again, this conditioned effect is reduced by
inactivation of the BLA. This effect was evident at both the protein and mRNA level in the spleen
and liver with the exception of TNF‐α mRNA in the liver. As with IL‐1β, the lack of a significant
effect in liver TNF‐α mRNA is not surprising and the significance at the protein level suggests that
an effect may have been evident at an earlier timepoint. Analysis revealed a main effect of
treatment on both mRNA and protein levels in the spleen [F( 4,15)
4,15) = 27.644, P

<

=

6.946, P

0.01] and on protein levels in the liver [F( 4,15)

0.01]. In line with our previous experiments, the CS
lower levels of TNF‐α mRNA in the spleen (P
α protein in both the spleen and liver (P

< 0.01; F(

= 7.313, P

<

Saline‐BLA group exhibited significantly

< 0.05) and significantly lower levels of TNF‐

< 0.05) compared to the HC

Saline‐BLA group.

Graph: 7 Effect of treatments on LPS‐induced expression of TNF‐α mRNA and protein in (A and
C) the spleen and (B and D) the liver as determined by real‐time RT‐PCR. Re‐exposure to the
previously heroin‐paired environment (CS) reduced TNF‐α mRNA and protein in the spleen and

TNF‐α protein in liver tissue, and this reduction was attenuated by inactivation of the BLA. (A and
B) The RT‐PCR data are expressed as TNF‐α copy number per 10

ng cDNA based on a standard

curve using Roche LightCycler software. (C and D) The ELISA data are expressed as pg of protein
per ml. *P

< 0.05 vs. the HC

Saline‐BLA group.

Figure 8 shows that the suppressive effect of heroin on the proinflammatory cytokine TNF‐α was
not altered by inactivation of the caudate control region. The suppressive effect of conditioning
was evident at both the protein and mRNA level. Analysis revealed a main effect of treatment on
both mRNA and protein levels in the spleen [F( 4,15)

= 7.605, P

7.779, P

< 0.01; F( 4,15)

< 0.01] and liver [F( 4,15)

= 11.494, P

0.01]. In line with our previous experiments, the CS

< 0.01.; F( 4,15)
= 12.655, P

=
<

Saline‐Caud group exhibited significantly

lower levels of TNF‐α mRNA and protein in the spleen and in the liver compared to the HC
Saline‐Caud group. Inactivation of the caudate control region had no effect on this suppression as
the CS

Mus/Bac‐Caud group also showed significantly lower levels of TNF‐α protein and

mRNA as compared to the HC

Saline‐Caud group (P

< 0.05).

Graph: 8 Effect of treatments on LPS‐induced expression of TNF‐α mRNA and protein in (A and
C) the spleen and (B and D) the liver as determined by real‐time RT‐PCR. Re‐exposure to the
previously heroin‐paired environment (CS) reduced TNF‐α mRNA and protein in both spleen and
liver tissue, and this reduction was not attenuated by inactivation of the caudate control region. (A
and B) The RT‐PCR data are expressed as TNF‐α copy number per 10

ng cDNA based on a

standard curve using Roche LightCycler software. (C and D) The ELISA data are expressed as pg
of protein per mL. *P

<

0.05 vs. the HC

Saline‐Caud group.

Discussion

Previous research in our laboratory has shown that exposure to a previously drug‐paired
environment induces alterations in nitric oxide production similar to those observed upon actual
drug administration ([20]; [37]). The data presented here are the first to demonstrate that the
suppressive effects of heroin on the proinflammatory cytokines TNF‐α and IL1‐β may also be
conditioned to environmental stimuli. Both IL‐1β and TNF‐α are proinflammatory cytokines
involved in host defense. When secreted, both IL‐1β and TNF‐α have widespread effects in the
host including altering the thermoregulatory setting in the hypothalamus to produce fever and
increasing the expression of adhesion factors on endothelial cells to promote the transmigration of
leukocytes to sites of infection. In addition, it appears that both TNF‐α and IL‐1β are highly
involved in LPS‐induced septic shock. Rats with LPS‐induced septic shock exhibited a peak in
TNF‐α mRNA in plasma at 1

h post‐infection with levels beginning to decline by 2

administration. Similarly, IL‐1β peaked at 1
9

h after LPS

h post‐LPS and gradually returned to baseline over

h ([18]). The samples collected in this study were taken at 6

h post‐LPS injection to optimize

for LPS‐induced nitric oxide production. The ability of these manipulations to detect a significant
change in IL‐1β and TNF‐α demonstrates the robustness of these effects. Furthermore, given the
time course of these effects, the fact that some of the data failed to reveal significant differences
between treatment groups in levels of TNF‐α or IL‐1β mRNA in the liver is not surprising.
However, the significant reduction in TNF‐α and IL‐1β protein in liver tissue detected by the
ELISA suggests that mRNA levels for these cytokines may have been previously suppressed in
the group that was re‐exposed to the conditioned stimulus on test day but may have rebounded by
the 6‐h timepoint at which they were analyzed.

Given the multifaceted and complex involvement of these cytokines, as well as nitric oxide, in the
initial immune response to infectious challenge it is essential to understand the mechanisms and
neural circuitry through which heroin's conditioned alterations of these proinflammatory mediators
are controlled. The results presented here provide the first evidence that inactivation of the BLA
can reduce or even eliminate the conditioned suppressive effects of heroin on nitric oxide induction
and on the expression of the proinflammatory cytokines TNF‐α and IL‐1β. This attenuation
appears to encompass several organ systems as it is found in both spleen and liver tissues as well
as in serum levels of nitrite/nitrate. In addition, the attenuation is apparent at both the mRNA and
protein levels, showing that the expression as well as the production of these mediators is altered.
The use of several control groups further demonstrates that these results are specific to the
manipulations used and not related to ancillary effects of the conditioning or surgical procedures.
Moreover, in order to ensure that these results were specific to the BLA, a control experiment was
conducted in which an area of the caudate situated dorsal to the BLA was inactivated. The
inactivation of this region of the caudate did not produce an attenuation of the conditioned
response, demonstrating that the results are specific to the BLA. These findings are consistent with
prior investigations showing that heroin‐induced alterations in immune status may be conditioned
to drug‐paired stimuli ([20]) and that these alterations are indeed a form of associative learning as
they are susceptible to both extinction and latent inhibition ([37]). In these previous investigations,
animals received subcutaneous injections of heroin upon placement in a distinctive environment.
Upon re‐exposure to that environment, in the absence of drug, the subjects exhibited a reduction
in nitric oxide production similar to what is observed with heroin treatment. Repeated exposure to
the distinctive environment without drug, either pre‐ (latent inhibition) or post‐conditioning

(extinction), abolished this conditioned effect. The present study extends these previous findings
by showing that the BLA, an area known to be involved in associative learning processes, is
required for the expression of these conditioned effects.

These results suggest that there exists a neural circuit, of which the BLA is an integral component,
which mediates these conditioned alterations in immune measures. Given the wealth of research
showing the involvement of the BLA in conditioned responses it is not surprising that this area
would be required for the expression of conditioned suppression of proinflammatory mediators.
Numerous investigators have demonstrated a role of the BLA in associative learning. For example,
lesions of the BLA block acquisition of classical eye blink conditioning ([ 1]), inhibit conditioned
fear responses to aversive stimuli in rats ([16]) and block acquisition of the motivational value of
an appetitive unconditioned stimulus ([33], [34]). In addition, learning of an inhibitory avoidance
task involves neuronal activity within the BLA ([ 3]), as does olfactory fear conditioning ([35])
and conditioning of odorant attractiveness in female mice ([22]). Furthermore, the BLA has been
implicated in the formation of new, and in the utilization of already established, stimulus–reward
associations within models of drug abuse. For example, inactivation of the BLA inhibits the
reacquisition of heroin‐seeking in a test of conditioned place preference ([28]). Similarly, it has
been demonstrated that inactivation of the BLA abolishes the expression of CS‐induced
reinstatement of heroin‐seeking behavior in rats ([10]). In addition, it has been shown that animals
receiving morphine paired with a distinct environment exhibit Fos protein expression, a marker of
neural activation, within both the BLA and the central nucleus of the amygdala during a test of
conditioned place preference ([13]).

The exact mechanism through which conditioned drug cues exert their effects on proinflammatory
mediators remains unknown, as does the means by which the BLA alters these effects. Studies
suggest that it is unlikely that the BLA itself has a direct effect on immune parameters as lesions
and/or inactivation of this area do not seem to induce changes in immune reactivity ([12]; [15]).
This is consistent with the data reported here as inactivation of the BLA, by itself, did not alter the
induction of proinflammatory mediators. While the BLA may not directly alter immune
parameters, previous work in our laboratory and others has shown several brain areas to which the
BLA is connected that have direct effects on the immune system; these include the central
amygdala and the nucleus accumbens. For instance, [14] reported increased monoamine utilization
in the central amygdala in response to systemic administration of TNF‐a, suggesting that this area
of the amygdala is sensitive to peripheral changes in cytokine production. In addition, research has
shown that systemic LPS administration induces c‐fos expression in the central amygdala ([27];
[30]; [38]) and infusion of dopamine D1 agonists directly into this area results in increased
Concanavalin A‐stimulated splenocyte proliferation ([23]; [ 2]). The BLA sends extensive
projections to the central amygdala and the communication between these two areas is thought to
create a circuit by which many conditioned responses are mediated ([25]; [29]; [17]). Likewise,
studies have shown that interactions between the BLA and the nucleus accumbens may be
necessary for the establishment and expression of some conditioned responses including cocaine‐
seeking induced by conditioned drug cues ([33], [34]; [ 8]). In addition, infusion of dopamine D1
antagonists into the nucleus accumbens shell blocks morphine‐induced suppression of natural
killer cell cytotoxicity while infusion of a D1 agonist recreates this suppression ([31]). These data
suggest that dopamine activity within the nucleus accumbens is both necessary and sufficient for
the induction of immune alterations. As inactivation of the BLA attenuates the conditioned effects

of heroin on proinflammatory mediators it is possible that information regarding the conditioned
stimulus is routed through the BLA to the nucleus accumbens and it is actually the nucleus
accumbens that directly influences immune alterations.

Considering the increased susceptibility to infection that occurs with opioid use it is possible that
the conditioned alterations in certain immune parameters that occur in response to exposure to
drug‐paired cues might also compromise immune function and increase susceptibility to disease.
The host's initial response to an immune challenge is a complex and highly regulated process.
Some of the key mediators involved in the initial response to potential pathogens are inducible
nitric oxide, IL‐1β and TNF‐α. Each of these immune system components is responsible for
numerous processes that together make up the response that is necessary to combat infectious
agents and to prepare the site of infection for repair and recovery. These results are important, not
only because they provide the first demonstration that the suppression of proinflammatory
cytokines can be conditioned to environmental stimuli paired with heroin administration but also
because they demonstrate that the expression of the conditioned effects of heroin on
proinflammatory mediators require the BLA. These effects and the brain areas that control them
need to be factored into the comprehensive treatment of opiate users.
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